google-site-verification: google28f501b00d980d5f.html Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market - Vetpol Community

Announcement

Collapse
No announcement yet.

Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market

Collapse
X
Collapse

  • Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market

    Click image for larger version

Name:	Boehringer.jpg
Views:	20
Size:	35.4 KB
ID:	48169
    The Boehringer Ingelheim Animal Health Business Unit and Global Stem Cell Technology (GST) entered into a partnership to enable European veterinarians and horse owners to benefit from ground-breaking innovation. Following marketing authorisation, Boehringer Ingelheim will exclusively distribute this highly innovative product in the EU. The product has been developed by GST and is the first-ever stem cell product in the veterinary world1 which was recommended marketing authorisation by the European Medicines Agency (EMA)1 earlier this year.

    Based on horse-blood-derived stem cells, which are specially primed, this medication is a candidate of the so-called novel therapies.

    Lameness is a common disease in horses and impacts their performance as well as welfare. Current treatment is not satisfactory for all cases and there is a clear need for innovation and new treatment options. Hence, the significant interest in treatment beyond symptoms, namely combatting the underlying root cause.

    “Priming the cells towards cartilage aids them to deliver the right activities in the affected joint,” shares Jan Spaas PhD, Veterinarian and CEO of GST. “We are absolutely delighted with this partnership as well as EMA´s positive opinion - the potential for the treatment is vast, since a quarter of the entire equine population develops osteoarthritis at some point in their life.”

    “Boehringer Ingelheim is dedicated to providing new and innovative products, whether through our own R&D activities or by working in partnership with true experts in the field,” says Dr. Erich Schoett, Head of Strategic Business Unit Equine at Boehringer Ingelheim. “GST impressed us with a wealth of expertise in the area of regenerative medicine and we do see an immense synergy in the close collaboration we are having. It is a real privilege to launch an industry first of this magnitude and we are working together closely to bringing this product to market.”

    1Press release issued by the European Medicines Agency on 22 June 2018: https://www.ema.europa.eu/en/news/fi...-authorisation
    Brought to you by Boehringer Ingelheim Animal Health UK Ltd.

    Further information available from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email:vetenquiries@boehringer-ingelheim.com. ©2019 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: Dec 2018 AHD11801. Use Medicines Responsibly.

    Boehringer Ingelheim
    Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
    Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
    As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
    More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

    Boehringer Ingelheim Animal Health Business Unit
    Boehringer Ingelheim is the second largest animal health business in the world. We are committed to creating animal wellbeing through our large portfolio of advanced, preventive healthcare products and services. With net sales of 3.9 billion euros (2017) and around 10,000 employees worldwide, we are present in more than 150 markets. For more information click here.

    Global Stem cell Technology NV
    GST is a privately owned company supported by Anacura and PMV. The main activities of GST are research and development and production of veterinary stem cell based products and their biotechnological applications. As a basis for stem cell therapies, GST uses highly potent stem cells from blood of mammals. GST thus translates regenerative medicine into clinical applications. The company was founded by veterinary stem cell researcher Jan H. Spaas (CEO) who is inventor of six patents and leading author on more than 25 scientifically peer-reviewed publications in this field. GST is globally ranked within the top 10 start-ups in animal health2. For more information, visit www.gst.be.

    2https://pages.agribusinessintelligence.informa.com/animal-pharm-disruptors-innovators-2018


      Posting comments is disabled.

    Categories

    Collapse

    Article Tags

    Collapse

    Latest Articles

    Collapse

    • Referral Vets Share Their Expertise at IVC Study Day
      Kristina Kisbee


      Referral vets from the leading referral centres in the South West came together on 7th March to provide a full day of CPD aimed at first opinion practices.

      A total of 86 vets took part in the event, set at the magnificent De Vere Tortworth Court Hotel in Gloucestershire. The study day involved presentation lectures in the morning, and round table learning in the afternoon. Delegates were also given a Top Tips Handbook to take away after the event for ongoing support.
      ...
      Today, 12:33 PM
    • Veterinary Students Invited to Apply for 2019 MSD Animal Health Bursaries
      Kristina Kisbee


      The 2019 MSD Animal Health Research Bursary for Veterinary Students has now been launched and students from universities across the UK are invited to apply. Five veterinary students have the opportunity to win an award of £1,000 for their research project, and an additional £1,000 top prize and £500 runner-up prize. The deadline for entries is Friday 10th May 2019.

      Michelle Townley, Veterinary Advisor at MSD Animal Health, comments: “Our student bursaries are a great
      ...
      Today, 12:30 PM
    • Vet required at Avenue Vet Centre - Grantham, Lincolnshire
      IVC
      We are looking for either a SA or a mixed vet to join our wonderful supportive, friendly and relaxed team.

      The successful candidate will be fully supported by our team of highly experienced vets and nurses and will be given the opportunity to develop interests and skills as desired. We are based in the historic market town of Grantham and we have an excellent base. OOH is covered within the team. Working 1:6 (1st and 2nd) rota with a 4 day week.

      CPD is encouraged and...
      Today, 12:13 PM
    • Vet required at Animals 1st Vet Surgery - Macmerry, East Lothian
      IVC
      Animals 1st are a small, friendly practice and we are looking for a caring, enthusiastic and caring Veterinary Surgeon.

      Ideally you will be at least 2-3 years qualified, a great team player with a compassionate and caring nature. We have a range of modern equipment including digital ultrasound, digital x-ray, in-house lab and expert knowledge available amongst our team of vets, nurses and visiting specialists.

      We are ideally looking for a full time vet (part-time considered...
      Today, 11:01 AM
    • RVN required at Lakeview Vets - Kettering, Northamptonshire
      IVC
      Lake View Vet Centre are looking for a small animal Registered Veterinary Nurse to join their team in a peaceful, country location.

      This is a full time role with a flexible rota and 1 in 3 Saturday mornings 8:30-1pm, with time back the following week. Must be qualified, friendly and focused on excellent customer service with a can do attitude. Would be preferable to have clinical coaching experience and a desire to train...
      Today, 10:17 AM
    • Hendon Vet Team Helps Cats in Cyprus
      Kristina Kisbee


      A group of vets from Medivet Hendon is back at work after a mercy mission to Cyprus to neuter hundreds of stray cats. The team, led by vet and partner at Medivet Hendon, Dr Jerry Dunne, flew out to support local rescue Friends of Larnaca Cats. While there, they neutered more than 200 stray or feral cats and provided veterinary treatment to other animals in need. They found the project so rewarding that they are already planning to return in April.

      Cats are regarded by
      ...
      Today, 08:11 AM
    Working...
    X